Activin Receptor Type 1 Market Report

Global and Region Activin Receptor Type 1 Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 29, 2022
  • PAGES：150
  • REPORT CODE：GMM881005
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Activin Receptor Type 1 market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Activin Receptor Type 1market, defines the market attractiveness level of Activin Receptor Type 1 market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Activin Receptor Type 1 industry, describes the types of Activin Receptor Type 1 market, the applications of major players and the market size, and deeply analyzes the current situation of the global Activin Receptor Type 1 market and the development prospects and opportunities of Activin Receptor Type 1 industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Activin Receptor Type 1 market in Chapter 13.

    By Player:

    • Daiichi Sankyo Company Ltd

    • La Jolla Pharmaceutical Company

    • Oncodesign SA

    • Blueprint Medicines Corp

    • Tolero Pharmaceuticals Inc

    By Type:

    • LJPC-6417

    • TP-0184

    • Dipyridamole

    • Others

    By End-User:

    • Alport Syndrome

    • Chronic Kidney Disease

    • Kidney Fibrosis

    • Obesity

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Activin Receptor Type 1 Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Activin Receptor Type 1 Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Activin Receptor Type 1 Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Activin Receptor Type 1 Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Activin Receptor Type 1 Market Analysis and Outlook to 2022

    • 7.1 Global Activin Receptor Type 1 Consumption (2017-2022)

    • 7.2 United States Activin Receptor Type 1 Consumption (2017-2022)

    • 7.3 Europe Activin Receptor Type 1 Consumption (2017-2022)

    • 7.4 China Activin Receptor Type 1 Consumption (2017-2022)

    • 7.5 Japan Activin Receptor Type 1 Consumption (2017-2022)

    • 7.6 India Activin Receptor Type 1 Consumption (2017-2022)

    • 7.7 South Korea Activin Receptor Type 1 Consumption (2017-2022)

    8 Region and Country-wise Activin Receptor Type 1 Market Analysis and Outlook to 2028

    • 8.1 Global Activin Receptor Type 1 Consumption Forecast (2022-2028)

    • 8.2 United States Activin Receptor Type 1 Consumption Forecast (2022-2028)

    • 8.3 Europe Activin Receptor Type 1 Consumption Forecast (2022-2028)

    • 8.4 China Activin Receptor Type 1 Consumption Forecast (2022-2028)

    • 8.5 Japan Activin Receptor Type 1 Consumption Forecast (2022-2028)

    • 8.6 India Activin Receptor Type 1 Consumption Forecast (2022-2028)

    • 8.7 South Korea Activin Receptor Type 1 Consumption Forecast (2022-2028)

    9 Global Activin Receptor Type 1 Market Outlook by Types and Applications to 2022

    • 9.1 Global Activin Receptor Type 1 Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global LJPC-6417 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global TP-0184 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Dipyridamole Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Activin Receptor Type 1 Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Alport Syndrome Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Chronic Kidney Disease Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Kidney Fibrosis Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Obesity Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Activin Receptor Type 1 Market Outlook by Types and Applications to 2028

    • 10.1 Global Activin Receptor Type 1 Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global LJPC-6417 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global TP-0184 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Dipyridamole Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Activin Receptor Type 1 Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Alport Syndrome Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Chronic Kidney Disease Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Kidney Fibrosis Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Obesity Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Activin Receptor Type 1 Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Activin Receptor Type 1 Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Activin Receptor Type 1 Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Activin Receptor Type 1 Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Activin Receptor Type 1 Market Competitive Analysis

    • 14.1 Daiichi Sankyo Company Ltd

      • 14.1.1 Daiichi Sankyo Company Ltd Company Details

      • 14.1.2 Daiichi Sankyo Company Ltd Activin Receptor Type 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Daiichi Sankyo Company Ltd Activin Receptor Type 1 Product and Service

    • 14.2 La Jolla Pharmaceutical Company

      • 14.2.1 La Jolla Pharmaceutical Company Company Details

      • 14.2.2 La Jolla Pharmaceutical Company Activin Receptor Type 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 La Jolla Pharmaceutical Company Activin Receptor Type 1 Product and Service

    • 14.3 Oncodesign SA

      • 14.3.1 Oncodesign SA Company Details

      • 14.3.2 Oncodesign SA Activin Receptor Type 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Oncodesign SA Activin Receptor Type 1 Product and Service

    • 14.4 Blueprint Medicines Corp

      • 14.4.1 Blueprint Medicines Corp Company Details

      • 14.4.2 Blueprint Medicines Corp Activin Receptor Type 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Blueprint Medicines Corp Activin Receptor Type 1 Product and Service

    • 14.5 Tolero Pharmaceuticals Inc

      • 14.5.1 Tolero Pharmaceuticals Inc Company Details

      • 14.5.2 Tolero Pharmaceuticals Inc Activin Receptor Type 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Tolero Pharmaceuticals Inc Activin Receptor Type 1 Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Activin Receptor Type 1

    • Figure Activin Receptor Type 1 Picture

    • Table Global Activin Receptor Type 1 Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Activin Receptor Type 1 Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Activin Receptor Type 1 Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Activin Receptor Type 1 Consumption by Country (2017-2022)

    • Figure United States Activin Receptor Type 1 Consumption and Growth Rate (2017-2022)

    • Table Europe Activin Receptor Type 1 Consumption and Growth Rate (2017-2022)

    • Figure China Activin Receptor Type 1 Consumption and Growth Rate (2017-2022)

    • Figure Japan Activin Receptor Type 1 Consumption and Growth Rate (2017-2022)

    • Figure India Activin Receptor Type 1 Consumption and Growth Rate (2017-2022)

    • Figure South Korea Activin Receptor Type 1 Consumption and Growth Rate (2017-2022)

    • Figure Global Activin Receptor Type 1 Consumption Forecast by Country (2022-2028)

    • Figure United States Activin Receptor Type 1 Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Activin Receptor Type 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Activin Receptor Type 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Activin Receptor Type 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Activin Receptor Type 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Activin Receptor Type 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global LJPC-6417 Consumption and Growth Rate (2017-2022)

    • Figure Global TP-0184 Consumption and Growth Rate (2017-2022)

    • Figure Global Dipyridamole Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Alport Syndrome Consumption and Growth Rate (2017-2022)

    • Figure Global Chronic Kidney Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Kidney Fibrosis Consumption and Growth Rate (2017-2022)

    • Figure Global Obesity Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global LJPC-6417 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global TP-0184 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Dipyridamole Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Alport Syndrome Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chronic Kidney Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Kidney Fibrosis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Obesity Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Activin Receptor Type 1 Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Activin Receptor Type 1 Export by Region (Top 5 Countries) (2017-2028)

    • Table Daiichi Sankyo Company Ltd (Foundation Year, Company Profile and etc.)

    • Table Daiichi Sankyo Company Ltd Activin Receptor Type 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Daiichi Sankyo Company Ltd Activin Receptor Type 1 Product and Service

    • Table La Jolla Pharmaceutical Company (Foundation Year, Company Profile and etc.)

    • Table La Jolla Pharmaceutical Company Activin Receptor Type 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table La Jolla Pharmaceutical Company Activin Receptor Type 1 Product and Service

    • Table Oncodesign SA (Foundation Year, Company Profile and etc.)

    • Table Oncodesign SA Activin Receptor Type 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Oncodesign SA Activin Receptor Type 1 Product and Service

    • Table Blueprint Medicines Corp (Foundation Year, Company Profile and etc.)

    • Table Blueprint Medicines Corp Activin Receptor Type 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Blueprint Medicines Corp Activin Receptor Type 1 Product and Service

    • Table Tolero Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Tolero Pharmaceuticals Inc Activin Receptor Type 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tolero Pharmaceuticals Inc Activin Receptor Type 1 Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US